Çelik Aykut, Altan Lale, Ökmen Burcu Metin
Altern Ther Health Med. 2020 Mar;26(2):54-60.
Low back pain is the most common form of pain related to the musculoskeletal system disorders. ESWT has been suggested as a new treatment modality in CLBP and its effectiveness has been investigated in a small number of studies.
The aim of this study is to investigate the effect of Extracorporeal Shockwave Therapy (ESWT) on pain, functional status, and quality of life compared to placebo in chronic low back pain (CLBP) patients.
METHODS/DESIGN: Prospective, randomized, placebo-controlled, double-blind study.
The study occurred at the University Of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Department of Physical Medicine and Rehabilitation (Bursa, Turkey).
Participants were 45 patients with CLBP.
Participants were randomized into 2 groups. Group 1 (n = 25) received ESWT and Group 2 (n = 20) received placebo ESWT.
The patients were assessed by using Numerical Rating Scale (NRS), Oswestry Disability Index (ODI), Hospital Anxiety and Depression Scale (HADS), Short-form 36 (SF-36). The data were obtained before treatment (W0), at sixth (W6) and twelfth week (W12).
In Group 1, statistically significant improvement was found in all parameters of rest and movement NRS, ODI, HADS and SF-36 except for emotional role at both W6 and W12 compared to W0(P < .05). Comparison of the difference scores of the two groups showed significantly superior improvement in Group 1 for all parameters at both W6 and W12 (P < .05).
The results of our study have shown that ESWT had a statistically significant superiority over placebo for improvement in the parameters of pain, disability, depression, anxiety, and quality of life in the patients with CLBP.
腰痛是与肌肉骨骼系统疾病相关的最常见疼痛形式。体外冲击波疗法(ESWT)已被提议作为慢性下腰痛(CLBP)的一种新治疗方式,并且其有效性已在少数研究中得到调查。
本研究旨在调查与安慰剂相比,体外冲击波疗法(ESWT)对慢性下腰痛(CLBP)患者疼痛、功能状态和生活质量的影响。
方法/设计:前瞻性、随机、安慰剂对照、双盲研究。
该研究在土耳其布尔萨市于克谢希尔培训与研究医院健康科学大学物理医学与康复科进行。
45例CLBP患者。
参与者被随机分为两组。第1组(n = 25)接受ESWT,第2组(n = 20)接受安慰剂ESWT。
使用数字评分量表(NRS)、Oswestry功能障碍指数(ODI)、医院焦虑抑郁量表(HADS)、简明健康调查问卷(SF - 36)对患者进行评估。在治疗前(W0)、第6周(W6)和第12周(W12)获取数据。
在第1组中,与W0相比,在W6和W12时,除情感角色外,静息和活动时的NRS、ODI、HADS和SF - 36的所有参数均有统计学意义的改善(P <.05)。两组差异评分的比较显示,在W6和W12时,第1组在所有参数上的改善均显著优于第2组(P <.05)。
我们的研究结果表明,在改善CLBP患者的疼痛、残疾、抑郁、焦虑和生活质量参数方面,ESWT在统计学上显著优于安慰剂。